Top Highlights for February 2014:  (Please click on read more to see details)

1. Pharma sales in India expected to rise by 14.4 per cent to USD 27 billion in 2016:Deloitte. Read more
2. Merck in partnership with Brazil's Bionovis & India's Dr. Reddy's Lab to step up its push into biosimilars which is forecasted to be worth $25 bn by 2020. Read more
3. GlaxoSmithKline to raise its stake in Indian Pharma Unit by spending close to $2 billion. Read more
4. India PE investments in healthcare & LifeScience sector increased from $191 million in Q3 2013 to $729 million in Q4 2013 
5. Lupin, India acquired Dutch company Nanomi company to expand its business in patented products.
6. India's Jubilant expanded its drug discovery alliance with Belgium's Janssen Read more
7. French Pierre Fabre and India's Aurigene in collaboration agreement for a new cancer therapeutic.Read more
8. Cipla formed an India-specific strategic partnership with MSD to co-market anti HIV drug. Read more
9. Baxter erects global R&D center at Bangalore, India.

Featured Opportunities and Aagami Updates: (Please click on link to view details)

1.  Product Licensing opportunities:

• NEW ! Elores– to combat antimicrobial resistance – Looking for partner to Launch in US. Already launched in India and partnership completed for South Africa and South Korea.
• NEW ! Partnership sought for low cost, stable, safe, malaria cure which overcomes drug resistance and is ready for human clinical trials.